Ono Pharmaceutical Co., Ltd. Stock price

Equities

4528

JP3197600004

Pharmaceuticals

Market Closed - Japan Exchange 01:00:00 2024-02-22 am EST 5-day change 1st Jan Change
2,423 JPY 0.00% Intraday chart for Ono Pharmaceutical Co., Ltd. -0.84% -3.70%
Sales 2024 * 506B 3.36B Sales 2025 * 484B 3.21B Capitalization 1,150B 7.64B
Net income 2024 * 131B 871M Net income 2025 * 112B 741M EV / Sales 2024 * 2.04 x
Net cash position 2024 * 117B 779M Net cash position 2025 * 223B 1.48B EV / Sales 2025 * 1.92 x
P/E ratio 2024 *
8.9 x
P/E ratio 2025 *
10.4 x
Employees 3,761
Yield 2024 *
3.23%
Yield 2025 *
3.32%
Free-Float 77.42%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Ono Pharmaceutical Co., Ltd. - Special Call
InveniAI LLC Announces Collaboration with Ono Pharmaceutical for Target Discovery CI
Shattuck Labs Collaborates With Ono Pharmaceutical to Develop Fusion Proteins MT
Shattuck Strikes Joint Development Deal With Japan's Ono Pharma DJ
Tranche Update on Ono Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 25, 2023. CI
Ono Pharmaceutical Co., Ltd. Enters into Collaboration Agreement with EVQLV to Generate Novel Antibodies against Multiple Targets Utilizing EVQLV's AI-powered Antibody Design Engine for Development of Innovative Antibody Drugs CI
Ono Enters into Research Collaboration with UK Dementia Research Institute CI
Biomed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research CI
Ono Pharmaceutical Co., Ltd.(TSE:4528) dropped from TOPIX 100 INDEX (NEW INDEX SERIES) CI
Turbine Simulated Cell Technologies Ltd. Establishes Research Collaboration with Ono Pharmaceutical Co., Ltd. to Identify and Validate Novel Oncology Targets CI
Tranche Update on Ono Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 25, 2023. CI
Ono Pharmaceutical Co., Ltd. Enters into A Drug Discovery Collaboration Agreement with Adimab to Discover Novel Antibody Drugs in the Oncology Field CI
Twist Bioscience Partners With Ono Pharmaceutical on Drug Discovery MT
Ono Pharmaceutical Co., Ltd. announces an Equity Buyback for 19,000,000 shares, representing 3.89% for ¥50,000 million. CI
Ono Pharmaceutical Co., Ltd. authorizes a Buyback Plan. CI
More news

Latest transcript on Ono Pharmaceutical Co., Ltd.

1 week-0.84%
Current month-9.32%
1 month-8.05%
3 months-14.95%
6 months-12.40%
Current year-3.70%
More quotes
1 week
2 404.50
Extreme 2404.5
2 465.00
1 month
2 377.50
Extreme 2377.5
2 672.00
Current year
2 377.50
Extreme 2377.5
2 777.00
1 year
2 377.50
Extreme 2377.5
2 966.50
3 years
2 361.50
Extreme 2361.5
3 990.00
5 years
1 822.00
Extreme 1822
3 990.00
10 years
1 542.00
Extreme 1542
5 880.00
More quotes
Managers TitleAgeSince
President 65 83-03-31
Chief Tech/Sci/R&D Officer - -
Director/Board Member 64 85-03-31
Members of the board TitleAgeSince
Director/Board Member 65 81-03-31
Director/Board Member 74 -
President 65 83-03-31
More insiders
Date Price Change Volume
24-02-22 2,423 0.00% 2,410,300
24-02-21 2,423 -1.40% 2,496,200
24-02-20 2,458 +1.63% 2,153,300
24-02-19 2,418 -1.04% 1,830,400
24-02-16 2,444 +2.56% 1,841,500

Delayed Quote Japan Exchange, February 22, 2024 at 01:00 am EST

More quotes
ONO PHARMACEUTICAL CO., LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates in one business segment. The Pharmaceutical segment involves in the manufacture and sale of drugs for medical and general use. The Company also involves in the clinical development, introduction and derivation of pharmaceuticals.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
2,423 JPY
Average target price
2,705 JPY
Spread / Average Target
+11.65%
Consensus
  1. Stock
  2. Equities
  3. Stock Ono Pharmaceutical Co., Ltd. - Japan Exchange
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer